Molecular Diagnostics Market Size, Share & Trends Report

Molecular Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR, INAAT, Sequencing, Mass Spectrometry, TMA), By Product, By Test Location, By Application, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Apr, 2021
  • Base Year for Estimate: 2020
  • Report ID: 978-1-68038-086-6
  • Format: Electronic (PDF)
  • Historical Data: 2017 - 2019
  • Number of Pages: 270

Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Market Segmentation
                       1.1.1 Estimates and Forecast Timeline
                 1.2 Research Methodology
                 1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Secondary Sources
                       1.3.3 Primary Research
                       1.3.4 Details of Primary Research
                 1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                 1.5 Market Formulation & Validation
                 1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                            1.6.1.1 Approach 1: Commodity flow approach
                            1.6.1.2 Approach 2: Country wise market estimation using bottom up approach
                 1.7 Global Market: CAGR Calculation
                 1.8 Research Assumptions
                 1.9 List of Secondary Sources
                 1.10 List of Primary Sources
                 1.11 Objectives
                       1.11.1 Objective 1:
                       1.11.2 Objective 2:
                 1.12 List of Abbreviations
Chapter 2 Executive Summary
                 2.1 Market Summary
Chapter 3 Molecular Diagnostics Market Variables, Trends & Scope
                 3.1 Molecular Diagnostics Market Lineage Outlook
                       3.1.1 Parent market outlook
                 3.2 Penetration & Growth Prospect Mapping
                 3.3 Regulatory and Reimbursement Framework
                 3.4 CLIA Waived Tests and Instruments
                 3.5 Market Dynamics
                       3.5.1 Market Driver Analysis
                            3.5.1.1 Increase in geriatric population
                            3.5.1.2 Introduction of technologically advanced products
                            3.5.1.3 Increase in demand for point-of-care facilities
                            3.5.1.4 Growing prevalence of target diseases
                            3.5.1.5 Increasing external funding for R&D
                            3.5.1.6 Outbreak of COVID-19
                       3.5.2 Market Restraint Analysis
                            3.5.2.1 Presence of ambiguous regulatory framework
                            3.5.2.2 High prices of molecular diagnostics tests
                 3.6 Molecular Diagnostics Market Analysis Tools
                       3.6.1 Porter’s Five Forces Analysis
                       3.6.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
                       3.6.3 Major Deals & Strategic Alliances Analysis
                            3.6.3.1 New product launch
                            3.6.3.2 Mergers and acquisitions
                            3.6.3.3 Expansion
                            3.6.3.4 Partnerships
                            3.6.3.5 Marketing & promotions
                            3.6.3.6 Market entry strategies
Chapter 4 Molecular Diagnostics Market - Competitive Analysis
                 4.1 Recent Developments & Impact Analysis, by Key Market Participants
                       4.1.1 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
                       4.1.2 Innovators
                       4.1.3 Key Differentiators
                 4.2 Vendor Landscape
                       4.2.1 List of key distributors
                       4.2.2 Key Company Market Share Analysis, 2020
                            4.2.2.1 Market share analysis, by Application, 2020
                                 4.2.2.1.1 Market share analysis, Molecular diagnostics, Oncology, 2020
                                 4.2.2.1.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
                                 4.2.2.1.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
                                 4.2.2.1.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
                                 4.2.2.1.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
                            4.2.2.2 Market share analysis, by Technology, 2020
                                 4.2.2.2.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
                                 4.2.2.2.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
                                 4.2.2.2.3 Market share analysis, Molecular diagnostics, INAAT, 2020
                                 4.2.2.2.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
                                 4.2.2.2.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
                                 4.2.2.2.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
                                 4.2.2.2.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
                            4.2.2.3 Market share analysis, by Application, 2020
                                 4.2.2.3.1 Market share analysis, Molecular diagnostics, Oncology, 2020
                                 4.2.2.3.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
                                 4.2.2.3.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
                                 4.2.2.3.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
                                 4.2.2.3.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
                            4.2.2.4 Market share analysis, by Technology, 2020
                                 4.2.2.4.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
                                 4.2.2.4.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
                                 4.2.2.4.3 Market share analysis, Molecular diagnostics, INAAT, 2020
                                 4.2.2.4.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
                                 4.2.2.4.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
                                 4.2.2.4.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
                                 4.2.2.4.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
                            4.2.2.5 Market share analysis, by Application, 2020
                                 4.2.2.5.1 Market share analysis, Molecular diagnostics, Oncology, 2020
                                 4.2.2.5.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
                                 4.2.2.5.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
                                 4.2.2.5.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
                                 4.2.2.5.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
                            4.2.2.6 Market share analysis, by Technology, 2020
                                 4.2.2.6.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
                                 4.2.2.6.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
                                 4.2.2.6.3 Market share analysis, Molecular diagnostics, INAAT, 2020
                                 4.2.2.6.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
                                 4.2.2.6.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
                                 4.2.2.6.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
                                 4.2.2.6.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
                            4.2.2.7 Market share analysis, by Application, 2020
                                 4.2.2.7.1 Market share analysis, Molecular diagnostics, Oncology, 2020
                                 4.2.2.7.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
                                 4.2.2.7.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
                                 4.2.2.7.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
                                 4.2.2.7.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
                            4.2.2.8 Market share analysis, by Technology, 2020
                                 4.2.2.8.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
                                 4.2.2.8.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
                                 4.2.2.8.3 Market share analysis, Molecular diagnostics, INAAT, 2020
                                 4.2.2.8.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
                                 4.2.2.8.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
                                 4.2.2.8.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
                                 4.2.2.8.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
                            4.2.2.9 Market share analysis, by Application, 2020
                                 4.2.2.9.1 Market share analysis, Molecular diagnostics, Oncology, 2020
                                 4.2.2.9.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
                                 4.2.2.9.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
                                 4.2.2.9.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
                                 4.2.2.9.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
                            4.2.2.10 Market share analysis, by Technology, 2020
                                 4.2.2.10.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
                                 4.2.2.10.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
                                 4.2.2.10.3 Market share analysis, Molecular diagnostics, INAAT, 2020
                                 4.2.2.10.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
                                 4.2.2.10.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
                                 4.2.2.10.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
                                 4.2.2.10.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
                            4.2.2.11 Market share analysis, by Application, 2020
                                 4.2.2.11.1 Market share analysis, Molecular diagnostics, Oncology, 2020
                                 4.2.2.11.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
                                 4.2.2.11.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
                                 4.2.2.11.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
                                 4.2.2.11.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
                            4.2.2.12 Market share analysis, by Technology, 2020
                                 4.2.2.12.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
                                 4.2.2.12.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
                                 4.2.2.12.3 Market share analysis, Molecular diagnostics, INAAT, 2020
                                 4.2.2.12.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
                                 4.2.2.12.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
                                 4.2.2.12.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
                                 4.2.2.12.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
                 4.3 Public Companies
                       4.3.1 Company Market Position Analysis (2020)
                       4.3.2 Competitive Dashboard Analysis
                 4.4 Private Companies
                       4.4.1 List of Key Emerging Companies /Technology Disruptors/Innovators
                       4.4.2 Regional Network Map
                       4.4.3 Competitive Dashboard Analysis
Chapter 5 Products Business Analysis
                 5.1 Molecular Diagnostics Market: Products Movement Analysis
                       5.1.1 Instruments
                            5.1.1.1 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
                       5.1.2 Reagents
                            5.1.2.1 Reagents market estimates and forecast, 2017 - 2028 (USD Million)
                       5.1.3 Others
                            5.1.3.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 6 Test Location Business Analysis
                 6.1 Molecular Diagnostics Market: Test Location Movement Analysis
                       6.1.1 Point-of-Care
                            6.1.1.1 Point-of-care market estimates and forecast, 2017 - 2028 (USD Million)
                       6.1.2 Self-testing or Over the Counter
                            6.1.2.1 Self-testing or over the counter market estimates and forecast, 2017 - 2028 (USD Million)
                       6.1.3 Central Laboratories
                            6.1.3.1 Central laboratories market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 7 Technology Business Analysis
                 7.1 Molecular Diagnostics Market: Technology Movement Analysis
                       7.1.1 Polymerase Chain Reaction (PCR)
                            7.1.1.1 Polymerase chain reaction market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.1.2 Nucleic acid extraction and purification
                            7.1.1.3 Nucleic Acid Extraction and purification market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.1.4 Others
                            7.1.1.5 Others market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.1.6 Polymerase chain reaction market, by Type
                                 7.1.1.6.1 Multiplex PCR
                                 7.1.1.6.1.1 Multiplex PCR market estimates and forecast, 2017 - 2028 (USD Million)
                                 7.1.1.6.2 Other PCR
                                 7.1.1.6.2.1 Other PCR market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.1.7 Polymerase Chain Reaction (PCR) market, By Product
                                 7.1.1.7.1 Instruments
                                 7.1.1.7.1.1 Instruments PCR market estimates and forecast, 2017 - 2028 (USD Million)
                                 7.1.1.7.2 Reagents
                                 7.1.1.7.2.1 Reagents PCR market estimates and forecast, 2017 - 2028 (USD Million)
                                 7.1.1.7.3 Others
                                 7.1.1.7.3.1 Others PCR market estimates and forecast, 2017 - 2028 (USD Million)
                       7.1.2 In Situ Hybridization (ISH)
                            7.1.2.1 In Situ Hybridization market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.2.2 Instruments
                                 7.1.2.2.1 Instruments ISH market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.2.3 Reagents
                                 7.1.2.3.1 Reagents ISH market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.2.4 Others
                            7.1.2.4.1 Others ISH market estimates and forecast, 2017 - 2028 (USD Million)
                       7.1.3 INAAT
                            7.1.3.1 INAAT market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.3.2 Instruments
                                 7.1.3.2.1 Instruments INAAT market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.3.3 Reagents
                                 7.1.3.3.1 Reagents INAAT market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.3.4 Others
                                 7.1.3.4.1 Others INAAT market estimates and forecast, 2017 - 2028 (USD Million)
                       7.1.4 Chips and Microarrays
                            7.1.4.1 Chips and Microarrays market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.4.2 Instruments
                                 7.1.4.2.1 Instruments chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.4.3 Reagents
                                 7.1.4.3.1 Reagents chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.4.4 Others
                                 7.1.4.4.1 Others chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
                       7.1.5 Mass Spectrometry
                            7.1.5.1 Mass Spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.5.2 Instruments
                                 7.1.5.2.1 Instruments mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.5.3 Reagents
                                 7.1.5.3.1 Reagents mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.5.4 Others
                                 7.1.5.4.1 Others mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
                       7.1.6 Sequencing
                            7.1.6.1 Sequencing market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.6.2 Instruments
                                 7.1.6.2.1 Instruments sequencing market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.6.3 Reagents
                                 7.1.6.3.1 Reagents sequencing market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.6.4 Others
                                 7.1.6.4.1 Others sequencing market estimates and forecast, 2017 - 2028 (USD Million)
                       7.1.7 Transcription Mediated Amplification (TMA)
                            7.1.7.1 Transcription mediated amplification market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.7.2 Instruments
                                 7.1.7.2.1 Instruments TMA market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.7.3 Reagents
                                 7.1.7.3.1 Reagents TMA market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.7.4 Others
                                 7.1.7.4.1 Others TMA market estimates and forecast, 2017 - 2028 (USD Million)
                       7.1.8 Others
                            7.1.8.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.8.2 Instruments
                                 7.1.8.2.1 Instruments others market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.8.3 Reagents
                                 7.1.8.3.1 Reagents others market estimates and forecast, 2017 - 2028 (USD Million)
                            7.1.8.4 Others
                                 7.1.8.4.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 8 Application Business Analysis
                 8.1 Molecular Diagnostics Market: Application Movement Analysis
                       8.1.1 Oncology
                            8.1.1.1 Oncology market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.1.2 Breast cancer
                                 8.1.1.2.1 Breast cancer market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.1.3 Prostate cancer
                                 8.1.1.3.1 Prostate cancer market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.1.4 Colorectal cancer
                                 8.1.1.4.1 Colorectal cancer market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.1.5 Cervical cancer
                                 8.1.1.5.1 Cervical cancer market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.1.6 Kidney cancer
                                 8.1.1.6.1 Kidney cancer market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.1.7 Liver cancer
                                 8.1.1.7.1 Liver cancer market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.1.8 Blood cancer
                                 8.1.1.8.1 Blood cancer market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.1.9 Lung cancer
                                 8.1.1.9.1 Lung cancer market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.1.10 Other cancers
                                 8.1.1.10.1 Other cancer market estimates and forecast, 2017 - 2028 (USD Million)
                       8.1.2 Pharmacogenomics
                            8.1.2.1 Pharmacogenomics market estimates and forecast, 2017 - 2028 (USD Million)
                       8.1.3 Infectious Diseases
                            8.1.3.1 Infectious Diseases market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.2 Methicillin-resistant Staphylococcus Aureus (MRSA)
                                 8.1.3.2.1 MRSA market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.3 Clostridium difficile
                                 8.1.3.3.1 Clostridium difficile market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.4 Vancomycin-Resistant Enterococci (VRE)
                                 8.1.3.4.1 VRE market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.5 Carbapenem-resistant bacteria
                                 8.1.3.5.1 Carbapenem-resistant bacteria market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.6 Flu
                                 8.1.3.6.1 Flu market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.7 Respiratory Syncytial Virus (RSV)
                                 8.1.3.7.1 RSV market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.8 Candida
                                 8.1.3.8.1 Candida market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.9 Tuberculosis (TB) and drug-resistant TB
                                 8.1.3.9.1 TB and drug-resistant TB market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.10 Meningitis
                                 8.1.3.10.1 Meningitis market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.11 Gastrointestinal panel testing
                                 8.1.3.11.1 Gastrointestinal panel testing market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.12 Chlamydia
                                 8.1.3.12.1 Chlamydia market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.13 Gonorrhoea
                                 8.1.3.13.1 Gonorrhoea market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.14 HIV
                                 8.1.3.14.1 HIV market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.15 Hepatitis C
                                 8.1.3.15.1 Hepatitis C market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.16 Hepatitis B
                                 8.1.3.16.1 Hepatitis B market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.3.17 Other infectious disease
                                 8.1.3.17.1 Other infectious disease market estimates and forecast, 2017 - 2028 (USD Million)
                       8.1.4 Genetic Testing
                            8.1.4.1 Genetic testing market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.4.2 Newborn screening
                                 8.1.4.2.1 Newborn screening market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.4.3 Predictive and presymptomatic testing
                                 8.1.4.3.1 Predictive and presymptomatic testing market estimates and forecast, 2017 - 2028 (USD Million)
                            8.1.4.4 Other genetic testing
                                 8.1.4.4.1 Other genetic testing market estimates and forecast, 2017 - 2028 (USD Million)
                       8.1.5 Neurological Diseases
                            8.1.5.1 Neurological diseases market estimates and forecast, 2017 - 2028 (USD Million)
                       8.1.6 Cardiovascular Diseases
                            8.1.6.1 Cardiovascular diseases market estimates and forecast, 2017 - 2028 (USD Million)
                       8.1.7 Microbiology
                            8.1.7.1 Microbiology market estimates and forecast, 2017 - 2028 (USD Million)
                       8.1.8 Others
                            8.1.8.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 9 Regional Business Analysis
                 9.1 Molecular Diagnostics Market: Regional Movement Analysis
                       9.1.1 North America
                       9.1.2 North America, SWOT Analysis
                            9.1.2.1 North America market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.2.2 U.S.
                                 9.1.2.2.1 U.S. market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.2.3 Canada
                                 9.1.2.3.1 Canada market estimates and forecast, 2017 - 2028 (USD Million)
                       9.1.3 Europe
                       9.1.4 Europe, SWOT Analysis
                            9.1.4.1 Europe market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.2 U.K.
                                 9.1.4.2.1 U.K. market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.3 Germany
                                 9.1.4.3.1 Germany market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.4 France
                                 9.1.4.4.1 France market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.5 Spain
                                 9.1.4.5.1 Spain market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.6 Italy
                                 9.1.4.6.1 Italy market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.7 Belgium
                                 9.1.4.7.1 Belgium market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.8 Switzerland
                                 9.1.4.8.1 Switzerland market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.9 Netherlands
                                 9.1.4.9.1 Netherlands market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.10 Poland
                                 9.1.4.10.1 Poland market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.11 Austria
                                 9.1.4.11.1 Austria market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.12 Greece
                                 9.1.4.12.1 Greece market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.13 Sweden
                                 9.1.4.13.1 Sweden market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.14 Turkey
                                 9.1.4.14.1 Turkey market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.4.15 Finland
                                 9.1.4.15.1 Finland market estimates and forecast, 2017 - 2028 (USD Million)
                       9.1.5 Asia Pacific
                       9.1.6 Asia Pacific, SWOT Analysis
                            9.1.6.1 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.2 Japan
                                 9.1.6.2.1 Japan market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.3 China
                                 9.1.6.3.1 China market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.4 India
                                 9.1.6.4.1 India market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.5 Australia
                                 9.1.6.5.1 Australia market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.6 New Zealand
                                 9.1.6.6.1 New Zealand market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.7 Sri Lanka
                                 9.1.6.7.1 Sri Lanka market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.8 Malaysia
                                 9.1.6.8.1 Malaysia market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.9 Thailand
                                 9.1.6.9.1 Thailand market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.10 Vietnam
                                 9.1.6.10.1 Vietnam market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.6.11 Singapore
                                 9.1.6.11.1 Singapore market estimates and forecast, 2017 - 2028 (USD Million)
                       9.1.7 Latin America
                       9.1.8 Latin America, SWOT Analysis
                            9.1.8.1 Latin America market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.8.2 Brazil
                                 9.1.8.2.1 Brazil market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.8.3 Mexico
                                 9.1.8.3.1 Mexico market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.8.4 Colombia
                                 9.1.8.4.1 colombia market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.8.5 Chile
                                 9.1.8.5.1 Chile market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.8.6 Peru
                                 9.1.8.6.1 Peru market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.8.7 Argentina
                                 9.1.8.7.1 Argentina market estimates and forecast, 2017 - 2028 (USD Million)
                       9.1.9 Middle East & Africa
                       9.1.10 Middle East & Africa, SWOT Analysis
                       9.1.11 Middle East & Africa market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.11.1 South Africa
                                 9.1.11.1.1 South Africa market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.11.2 Saudi Arabia
                                 9.1.11.2.1 Saudi Arabia market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.11.3 Jordan
                                 9.1.11.3.1 Jordan market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.11.4 United Arab Emirates
                                 9.1.11.4.1 United Arab Emirates market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.11.5 Qatar
                                 9.1.11.5.1 Qatar market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.11.6 Nigeria
                                 9.1.11.6.1 Nigeria market estimates and forecast, 2017 - 2028 (USD Million)
                            9.1.11.7 Egypt
                                 9.1.11.7.1 Egypt market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 10 Company Profile
                 10.1 Market Participation Categorization
                 10.2 Company Profiles
                       10.2.1 Abbott
                            10.2.1.1 Company overview
                            10.2.1.2 Alere, Inc.
                            10.2.1.3 Financial performance
                            10.2.1.4 Product benchmarking
                            10.2.1.5 Strategic initiatives
                       10.2.2 Becton, Dickinson and Company
                            10.2.2.1 Company overview
                            10.2.2.2 Financial performance
                            10.2.2.3 Product benchmarking
                            10.2.2.4 Strategic initiatives
                       10.2.3 bioMérieux SA
                            10.2.3.1 Company overview
                            10.2.3.2 Financial performance
                            10.2.3.3 Product benchmarking
                            10.2.3.4 Strategic initiatives
                       10.2.4 Bio-Rad Laboratories, Inc.
                            10.2.4.1 Company overview
                            10.2.4.2 Financial performance
                            10.2.4.3 Product benchmarking
                            10.2.4.4 Strategic initiatives
                       10.2.5 Agilent Technologies, Inc.
                            10.2.5.1 Company overview
                            10.2.5.2 Financial performance
                            10.2.5.3 Product benchmarking
                            10.2.5.4 Strategic initiatives
                       10.2.6 Danaher Corporation
                            10.2.6.1 Company overview
                            10.2.6.2 Cepheid
                            10.2.6.3 Beckman Coulter
                            10.2.6.4 Leica Biosystems
                            10.2.6.5 Financial performance
                            10.2.6.6 Product benchmarking
                            10.2.6.7 Strategic initiatives
                            10.2.6.8 Strategic initiatives of Cepheid
                            10.2.6.9 Strategic initiatives of Beckman Coulter, Inc.
                            10.2.6.10 Strategic initiatives of Leica Biosystems
                       10.2.7 Hologic, Inc. (Gen Probe)
                            10.2.7.1 Company overview
                            10.2.7.2 Financial performance
                            10.2.7.3 Product benchmarking
                            10.2.7.4 Strategic initiatives
                       10.2.8 Illumina, Inc.
                            10.2.8.1 Company overview
                            10.2.8.2 Financial performance
                            10.2.8.3 Product benchmarking
                            10.2.8.4 Strategic initiatives
                       10.2.9 Johnson & Johnson Services, Inc.
                            10.2.9.1 Company overview
                            10.2.9.2 Financial performance
                            10.2.9.3 Product benchmarking
                            10.2.9.4 Strategic initiatives
                       10.2.10 GRIFOLs S.A.
                            10.2.10.1 Company overview
                            10.2.10.2 Financial performance
                            10.2.10.3 Product benchmarking
                            10.2.10.4 Strategic initiatives
                       10.2.11 Qiagen
                            10.2.11.1 Company overview
                            10.2.11.2 Financial performance
                            10.2.11.3 Product benchmarking
                            10.2.11.4 Strategic initiatives
                       10.2.12 F. Hoffmann-La Roche Ltd
                            10.2.12.1 Company overview
                            10.2.12.2 Financial performance
                            10.2.12.3 Product benchmarking
                            10.2.12.4 Strategic initiatives
                       10.2.13 Siemens Healtineers
                            10.2.13.1 Company overview
                            10.2.13.2 Financial performance
                            10.2.13.3 Product benchmarking
                            10.2.13.4 Strategic initiatives
                       10.2.14 Sysmex Corporation
                            10.2.14.1 Company overview
                            10.2.14.2 Financial performance
                            10.2.14.3 Product benchmarking
                            10.2.14.4 Strategic initiatives


List of Tables

TABLE 1 Country share estimation
TABLE 2 North America molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 3 North America molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 4 North America molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 5 North America PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 6 North America PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 7 North America ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 8 North America INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 9 North America chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 10 North America mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 11 North America sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 12 North America TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 13 North America others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 14 North America molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 15 North America molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 16 North America molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 17 North America molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 18 U.S. molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 19 U.S. molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 20 U.S. molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 21 U.S. PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 22 U.S. PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 23 U.S. ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 24 U.S. INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 25 U.S. chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 26 U.S. mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 27 U.S. sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 28 U.S. TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 29 U.S. others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 30 U.S. molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 31 U.S. molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 32 U.S. molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 33 U.S. molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 34 Canada molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 35 Canada molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 36 Canada molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 37 Canada PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 38 Canada PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 39 Canada ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 40 Canada INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 41 Canada chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 42 Canada mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 43 Canada sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 44 Canada TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 45 Canada others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 46 Canada molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 47 Canada molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 48 Canada molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 49 Canada molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 50 Europe molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 51 Europe molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 52 Europe molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 53 Europe PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 54 Europe PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 55 Europe ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 56 Europe INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 57 Europe chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 58 Europe mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 59 Europe sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 60 Europe TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 61 Europe others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 62 Europe molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 63 Europe molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 64 Europe molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 65 Europe molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 66 U.K. molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 67 U.K. molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 68 U.K. molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 69 U.K. PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 70 U.K. PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 71 U.K. ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 72 U.K. INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 73 U.K. chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 74 U.K. mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 75 U.K. sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 76 U.K. TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 77 U.K. others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 78 U.K. molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 79 U.K. molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 80 U.K. molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 81 U.K. molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 82 Germany molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 83 Germany molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 84 Germany molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 85 Germany PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 86 Germany PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 87 Germany ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 88 Germany INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 89 Germany chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 90 Germany mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 91 Germany sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 92 Germany TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 93 Germany others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 94 Germany molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 95 Germany molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 96 Germany molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 97 Germany molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 98 France molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 99 France molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 100 France molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 101 France PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 102 France PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 103 France ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 104 France INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 105 France chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 106 France mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 107 France sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 108 France TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 109 France others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 110 France molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 111 France molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 112 France molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 113 France molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 114 Spain molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 115 Spain molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 116 Spain molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 117 Spain PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 118 Spain PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 119 Spain ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 120 Spain INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 121 Spain chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 122 Spain mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 123 Spain sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 124 Spain TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 125 Spain others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 126 Spain molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 127 Spain molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 128 Spain molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 129 Spain molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 130 Italy molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 131 Italy molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 132 Italy molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 133 Italy PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 134 Italy PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 135 Italy ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 136 Italy INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 137 Italy chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 138 Italy mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 139 Italy sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 140 Italy TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 141 Italy others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 142 Italy molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 143 Italy molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 144 Italy molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 145 Italy molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 146 Belgium molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 147 Belgium molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 148 Belgium molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 149 Belgium PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 150 Belgium PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 151 Belgium ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 152 Belgium INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 153 Belgium chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 154 Belgium mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 155 Belgium sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 156 Belgium TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 157 Belgium others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 158 Belgium molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 159 Belgium molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 160 Belgium molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 161 Belgium molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 162 Switzerland molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 163 Switzerland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 164 Switzerland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 165 Switzerland PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 166 Switzerland PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 167 Switzerland ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 168 Switzerland INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 169 Switzerland chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 170 Switzerland mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 171 Switzerland sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 172 Switzerland TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 173 Switzerland others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 174 Switzerland molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 175 Switzerland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 176 Switzerland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 177 Switzerland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 178 Netherlands molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 179 Netherlands molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 180 Netherlands molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 181 Netherlands PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 182 Netherlands PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 183 Netherlands ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 184 Netherlands INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 185 Netherlands chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 186 Netherlands mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 187 Netherlands sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 188 Netherlands TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 189 Netherlands others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 190 Netherlands molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 191 Netherlands molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 192 Netherlands molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 193 Netherlands molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 194 Poland molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 195 Poland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 196 Poland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 197 Poland PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 198 Poland PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 199 Poland ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 200 Poland INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 201 Poland chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 202 Poland mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 203 Poland sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 204 Poland TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 205 Poland others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 206 Poland molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 207 Poland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 208 Poland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 209 Poland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 210 Austria molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 211 Austria molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 212 Austria molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 213 Austria PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 214 Austria PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 215 Austria ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 216 Austria INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 217 Austria chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 218 Austria mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 219 Austria sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 220 Austria TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 221 Austria others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 222 Austria molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 223 Austria molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 224 Austria molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 225 Austria molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 226 Greece molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 227 Greece molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 228 Greece molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 229 Greece PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 230 Greece PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 231 Greece ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 232 Greece INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 233 Greece chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 234 Greece mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 235 Greece sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 236 Greece TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 237 Greece others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 238 Greece molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 239 Greece molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 240 Greece molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 241 Greece molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 242 Sweden molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 243 Sweden molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 244 Sweden molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 245 Sweden PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 246 Sweden PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 247 Sweden ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 248 Sweden INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 249 Sweden chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 250 Sweden mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 251 Sweden sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 252 Sweden TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 253 Sweden others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 254 Sweden molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 255 Sweden molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 256 Sweden molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 257 Sweden molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 258 Turkey molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 259 Turkey molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 260 Turkey molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 261 Turkey PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 262 Turkey PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 263 Turkey ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 264 Turkey INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 265 Turkey chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 266 Turkey mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 267 Turkey sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 268 Turkey TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 269 Turkey others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 270 Turkey molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 271 Turkey molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 272 Turkey molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 273 Turkey molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 274 Finland molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 275 Finland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 276 Finland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 277 Finland PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 278 Finland PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 279 Finland ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 280 Finland INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 281 Finland chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 282 Finland mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 283 Finland sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 284 Finland TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 285 Finland others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 286 Finland molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 287 Finland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 288 Finland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 289 Finland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 290 Asia Pacific molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 291 Asia Pacific molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 292 Asia Pacific molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 293 Asia Pacific PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 294 Asia Pacific PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 295 Asia Pacific ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 296 Asia Pacific INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 297 Asia Pacific chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 298 Asia Pacific mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 299 Asia Pacific sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 300 Asia Pacific TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 301 Asia Pacific others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 302 Asia Pacific molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 303 Asia Pacific molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 304 Asia Pacific molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 305 Asia Pacific molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 306 Japan molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 307 Japan molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 308 Japan molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 309 Japan PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 310 Japan PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 311 Japan ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 312 Japan INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 313 Japan chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 314 Japan mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 315 Japan sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 316 Japan TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 317 Japan others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 318 Japan molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 319 Japan molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 320 Japan molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 321 Japan molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 322 China molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 323 China molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 324 China molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 325 China PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 326 China PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 327 China ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 328 China INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 329 China chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 330 China mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 331 China sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 332 China TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 333 China others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 334 China molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 335 China molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 336 China molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 337 China molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 338 India molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 339 India molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 340 India molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 341 India PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 342 India PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 343 India ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 344 India INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 345 India chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 346 India mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 347 India sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 348 India TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 349 India others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 350 India molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 351 India molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 352 India molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 353 India molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 354 Australia molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 355 Australia molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 356 Australia molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 357 Australia PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 358 Australia PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 359 Australia ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 360 Australia INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 361 Australia chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 362 Australia mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 363 Australia sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 364 Australia TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 365 Australia others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 366 Australia molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 367 Australia molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 368 Australia molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 369 Australia molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 370 New Zealand molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 371 New Zealand molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 372 New Zealand molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 373 New Zealand PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 374 New Zealand PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 375 New Zealand ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 376 New Zealand INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 377 New Zealand chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 378 New Zealand mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 379 New Zealand sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 380 New Zealand TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 381 New Zealand others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 382 New Zealand molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 383 New Zealand molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 384 New Zealand molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 385 New Zealand molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 386 Sri Lanka molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 387 Sri Lanka molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 388 Sri Lanka molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 389 Sri Lanka PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 390 Sri Lanka PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 391 Sri Lanka ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 392 Sri Lanka INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 393 Sri Lanka chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 394 Sri Lanka mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 395 Sri Lanka sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 396 Sri Lanka TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 397 Sri Lanka others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 398 Sri Lanka molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 399 Sri Lanka molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 400 Sri Lanka molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 401 Sri Lanka molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 402 Malaysia molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 403 Malaysia molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 404 Malaysia molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 405 Malaysia PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 406 Malaysia PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 407 Malaysia ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 408 Malaysia INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 409 Malaysia chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 410 Malaysia mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 411 Malaysia sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 412 Malaysia TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 413 Malaysia others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 414 Malaysia molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 415 Malaysia molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 416 Malaysia molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 417 Malaysia molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 418 Thailand molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 419 Thailand molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 420 Thailand molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 421 Thailand PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 422 Thailand PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 423 Thailand ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 424 Thailand INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 425 Thailand chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 426 Thailand mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 427 Thailand sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 428 Thailand TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 429 Thailand others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 430 Thailand molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 431 Thailand molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 432 Thailand molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 433 Thailand molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 434 Vietnam molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 435 Vietnam molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 436 Vietnam molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 437 Vietnam PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 438 Vietnam PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 439 Vietnam ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 440 Vietnam INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 441 Vietnam chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 442 Vietnam mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 443 Vietnam sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 444 Vietnam TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 445 Vietnam others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 446 Vietnam molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 447 Vietnam molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 448 Vietnam molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 449 Vietnam molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 450 Singapore molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 451 Singapore molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 452 Singapore molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 453 Singapore PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 454 Singapore PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 455 Singapore ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 456 Singapore INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 457 Singapore chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 458 Singapore mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 459 Singapore sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 460 Singapore TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 461 Singapore others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 462 Singapore molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 463 Singapore molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 464 Singapore molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 465 Singapore molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 466 Latin America molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 467 Latin America molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 468 Latin America molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 469 Latin America PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 470 Latin America PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 471 Latin America ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 472 Latin America INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 473 Latin America chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 474 Latin America mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 475 Latin America sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 476 Latin America TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 477 Latin America others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 478 Latin America molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 479 Latin America molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 480 Latin America molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 481 Latin America molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 482 Brazil molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 483 Brazil molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 484 Brazil molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 485 Brazil PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 486 Brazil PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 487 Brazil ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 488 Brazil INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 489 Brazil chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 490 Brazil mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 491 Brazil sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 492 Brazil TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 493 Brazil others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 494 Brazil molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 495 Brazil molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 496 Brazil molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 497 Brazil molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 498 Mexico molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 499 Mexico molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 500 Mexico molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 501 Mexico PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 502 Mexico PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 503 Mexico ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 504 Mexico INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 505 Mexico chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 506 Mexico mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 507 Mexico sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 508 Mexico TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 509 Mexico others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 510 Mexico molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 511 Mexico molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 512 Mexico molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 513 Mexico molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 514 Colombia molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 515 Colombia molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 516 Colombia molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 517 Colombia PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 518 Colombia PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 519 Colombia ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 520 Colombia INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 521 Colombia chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 522 Colombia mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 523 Colombia sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 524 Colombia TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 525 Colombia others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 526 Colombia molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 527 Colombia molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 528 Colombia molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 529 Colombia molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 530 Chile molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 531 Chile molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 532 Chile molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 533 Chile PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 534 Chile PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 535 Chile ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 536 Chile INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 537 Chile chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 538 Chile mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 539 Chile sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 540 Chile TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 541 Chile others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 542 Chile molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 543 Chile molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 544 Chile molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 545 Chile molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 546 Peru molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 547 Peru molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 548 Peru molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 549 Peru PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 550 Peru PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 551 Peru ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 552 Peru INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 553 Peru chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 554 Peru mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 555 Peru sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 556 Peru TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 557 Peru others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 558 Peru molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 559 Peru molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 560 Peru molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 561 Peru molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 562 Argentina molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 563 Argentina molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 564 Argentina molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 565 Argentina PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 566 Argentina PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 567 Argentina ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 568 Argentina INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 569 Argentina chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 570 Argentina mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 571 Argentina sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 572 Argentina TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 573 Argentina others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 574 Argentina molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 575 Argentina molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 576 Argentina molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 577 Argentina molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 578 MEA molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 579 MEA molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 580 MEA molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 581 MEA PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 582 MEA PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 583 MEA ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 584 MEA INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 585 MEA chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 586 MEA mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 587 MEA sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 588 MEA TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 589 MEA others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 590 MEA molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 591 MEA molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 592 MEA molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 593 MEA molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 594 South Africa molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 595 South Africa molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 596 South Africa molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 597 South Africa PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 598 South Africa PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 599 South Africa ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 600 South Africa INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 601 South Africa chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 602 South Africa mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 603 South Africa sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 604 South Africa TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 605 South Africa others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 606 South Africa molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 607 South Africa molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 608 South Africa molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 609 South Africa molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 610 Saudi Arabia molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 611 Saudi Arabia molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 612 Saudi Arabia molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 613 Saudi Arabia PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 614 Saudi Arabia PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 615 Saudi Arabia ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 616 Saudi Arabia INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 617 Saudi Arabia chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 618 Saudi Arabia mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 619 Saudi Arabia sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 620 Saudi Arabia TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 621 Saudi Arabia others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 622 Saudi Arabia molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 623 Saudi Arabia molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 624 Saudi Arabia molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 625 Saudi Arabia molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 626 Jordan molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 627 Jordan molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 628 Jordan molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 629 Jordan PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 630 Jordan PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 631 Jordan ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 632 Jordan INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 633 Jordan chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 634 Jordan mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 635 Jordan sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 636 Jordan TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 637 Jordan others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 638 Jordan molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 639 Jordan molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 640 Jordan molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 641 Jordan molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 642 UAE molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 643 UAE molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 644 UAE molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 645 UAE PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 646 UAE PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 647 UAE ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 648 UAE INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 649 UAE chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 650 UAE mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 651 UAE sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 652 UAE TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 653 UAE others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 654 UAE molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 655 UAE molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 656 UAE molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 657 UAE molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 658 Qatar molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 659 Qatar molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 660 Qatar molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 661 Qatar PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 662 Qatar PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 663 Qatar ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 664 Qatar INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 665 Qatar chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 666 Qatar mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 667 Qatar sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 668 Qatar TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 669 Qatar others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 670 Qatar molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 671 Qatar molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 672 Qatar molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 673 Qatar molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 674 Nigeria molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 675 Nigeria molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 676 Nigeria molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 677 Nigeria PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 678 Nigeria PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 679 Nigeria ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 680 Nigeria INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 681 Nigeria chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 682 Nigeria mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 683 Nigeria sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 684 Nigeria TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 685 Nigeria others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 686 Nigeria molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 687 Nigeria molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 688 Nigeria molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 689 Nigeria molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 690 Egypt molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 691 Egypt molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 692 Egypt molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 693 Egypt PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 694 Egypt PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 695 Egypt ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 696 Egypt INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 697 Egypt chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 698 Egypt mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 699 Egypt sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 700 Egypt TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 701 Egypt others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 702 Egypt molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 703 Egypt molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 704 Egypt molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 705 Egypt molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)


List of Figures

Fig. 1 Molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Molecular diagnostics market snapshot
Fig. 10 Parent market outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Global population by age group, 2017, 2020, & 2028
Fig. 14 General trend shifts from laboratory to point-of-care
Fig. 15 Market restrain relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (Political & legal, economic and technological)
Fig. 18 Strategy mapping
Fig. 19 Competition categorization
Fig. 20 Company market share analysis - Molecular diagnostics market, 2020
Fig. 21 Company market share analysis - Molecular diagnostics, oncology, 2020
Fig. 22 Company market share analysis - Molecular diagnostics, pharmacogenomics, 2020
Fig. 23 Company market share analysis - Molecular diagnostics, infectious diseases, 2020
Fig. 24 Company market share analysis - Molecular diagnostics, genetic testing, 2020
Fig. 25 Company market share analysis - Molecular diagnostics, others (neurological disease, cardiovascular diseases, microbiology, others), 2020
Fig. 26 Company market share analysis - Molecular diagnostics, polymerase chain reaction, 2020
Fig. 27 Company market share analysis - Molecular diagnostics, in situ hybridization, 2020
Fig. 28 Company market share analysis - Molecular diagnostics, INAAT, 2020
Fig. 29 Company market share analysis - Molecular diagnostics, chips & microarrays, 2020
Fig. 30 Company market share analysis - Molecular diagnostics, mass spectrometry, 2020
Fig. 31 Company market share analysis - Molecular diagnostics, sequencing, 2020
Fig. 32 Company market share analysis - Molecular diagnostics, transcription mediated amplification, 2020
Fig. 33 North America Company market share analysis - Molecular diagnostics, oncology, 2020
Fig. 34 North America Company market share analysis - Molecular diagnostics, pharmacogenomics, 2020
Fig. 35 North America Company market share analysis - Molecular diagnostics, infectious diseases, 2020
Fig. 36 North America Company market share analysis - Molecular diagnostics, genetic testing, 2020
Fig. 37 North America Company market share analysis - Molecular diagnostics, others (neurological disease, cardiovascular diseases, microbiology, others), 2020
Fig. 38 North America Company market share analysis - Molecular diagnostics, polymerase chain reaction, 2020
Fig. 39 North America Company market share analysis - Molecular diagnostics, in situ hybridization, 2020
Fig. 40 North America Company market share analysis - Molecular diagnostics, INAAT, 2020
Fig. 41 North America Company market share analysis - Molecular diagnostics, chips & microarrays, 2020
Fig. 42 North America Company market share analysis - Molecular diagnostics, mass spectrometry, 2020
Fig. 43 North America Company market share analysis - Molecular diagnostics, sequencing, 2020
Fig. 44 North America Company market share analysis - Molecular diagnostics, transcription mediated amplification, 2020
Fig. 45 Europe Company market share analysis - Molecular diagnostics, oncology, 2020
Fig. 46 Europe Company market share analysis - Molecular diagnostics, pharmacogenomics, 2020
Fig. 47 Europe Company market share analysis - Molecular diagnostics, infectious diseases, 2020
Fig. 48 Europe Company market share analysis - Molecular diagnostics, genetic testing, 2020
Fig. 49 Europe Company market share analysis - Molecular diagnostics, others (neurological disease, cardiovascular diseases, microbiology, others), 2020
Fig. 50 Europe Company market share analysis - Molecular diagnostics, polymerase chain reaction, 2020
Fig. 51 Europe Company market share analysis - Molecular diagnostics, in situ hybridization, 2020
Fig. 52 Europe Company market share analysis - Molecular diagnostics, INAAT, 2020
Fig. 53 Europe Company market share analysis - Molecular diagnostics, chips & microarrays, 2020
Fig. 54 Europe Company market share analysis - Molecular diagnostics, mass spectrometry, 2020
Fig. 55 Europe Company market share analysis - Molecular diagnostics, sequencing, 2020
Fig. 56 Europe Company market share analysis - Molecular diagnostics, transcription mediated amplification, 2020
Fig. 57 Asia Pacific Company market share analysis - Molecular diagnostics, oncology, 2020
Fig. 58 Asia Pacific Company market share analysis - Molecular diagnostics, pharmacogenomics, 2020
Fig. 59 Asia Pacific Company market share analysis - Molecular diagnostics, infectious diseases, 2020
Fig. 60 Asia Pacific Company market share analysis - Molecular diagnostics, genetic testing, 2020
Fig. 61 Asia Pacific Company market share analysis - Molecular diagnostics, others (neurological disease, cardiovascular diseases, microbiology, others), 2020
Fig. 62 Asia Pacific Company market share analysis - Molecular diagnostics, polymerase chain reaction, 2020
Fig. 63 Asia Pacific Company market share analysis - Molecular diagnostics, in situ hybridization, 2020
Fig. 64 Asia Pacific Company market share analysis - Molecular diagnostics, INAAT, 2020
Fig. 65 Asia Pacific Company market share analysis - Molecular diagnostics, chips & microarrays, 2020
Fig. 66 Asia Pacific Company market share analysis - Molecular diagnostics, mass spectrometry, 2020
Fig. 67 Asia Pacific Company market share analysis - Molecular diagnostics, sequencing, 2020
Fig. 68 Asia Pacific Company market share analysis - Molecular diagnostics, transcription mediated amplification, 2020
Fig. 69 LATAM Company market share analysis - Molecular diagnostics, oncology, 2020
Fig. 70 LATAM Company market share analysis - Molecular diagnostics, pharmacogenomics, 2020
Fig. 71 LATAM Company market share analysis - Molecular diagnostics, infectious diseases, 2020
Fig. 72 LATAM Company market share analysis - Molecular diagnostics, genetic testing, 2020
Fig. 73 LATAM Company market share analysis - Molecular diagnostics, others (neurological disease, cardiovascular diseases, microbiology, others), 2020
Fig. 74 LATAM Company market share analysis - Molecular diagnostics, polymerase chain reaction, 2020
Fig. 75 C LATAM ompany market share analysis - Molecular diagnostics, in situ hybridization, 2020
Fig. 76 LATAM Company market share analysis - Molecular diagnostics, INAAT, 2020
Fig. 77 LATAM Company market share analysis - Molecular diagnostics, chips & microarrays, 2020
Fig. 78 LATAM Company market share analysis - Molecular diagnostics, mass spectrometry, 2020
Fig. 79 LATAM Company market share analysis - Molecular diagnostics, sequencing, 2020
Fig. 80 LATAM Company market share analysis - Molecular diagnostics, transcription mediated amplification, 2020
Fig. 81 MEA Company market share analysis - Molecular diagnostics, oncology, 2020
Fig. 82 MEA Company market share analysis - Molecular diagnostics, pharmacogenomics, 2020
Fig. 83 MEA Company market share analysis - Molecular diagnostics, infectious diseases, 2020
Fig. 84 MEA Company market share analysis - Molecular diagnostics, genetic testing, 2020
Fig. 85 MEA Company market share analysis - Molecular diagnostics, others (neurological disease, cardiovascular diseases, microbiology, others), 2020
Fig. 86 MEA Company market share analysis - Molecular diagnostics, polymerase chain reaction, 2020
Fig. 87 MEA Company market share analysis - Molecular diagnostics, in situ hybridization, 2020
Fig. 88 MEA Company market share analysis - Molecular diagnostics, INAAT, 2020
Fig. 89 MEA Company market share analysis - Molecular diagnostics, chips & microarrays, 2020
Fig. 90 MEA Company market share analysis - Molecular diagnostics, mass spectrometry, 2020
Fig. 91 MEA Company market share analysis - Molecular diagnostics, sequencing, 2020
Fig. 92 MEA Company market share analysis - Molecular diagnostics, transcription mediated amplification, 2020
Fig. 93 Company market position analysis
Fig. 94 Competitive dashboard analysis
Fig. 95 Regional network map
Fig. 96 Competitive Dashboard Analysis
Fig. 97 Molecular diagnostics market: Product outlook and key takeaways
Fig. 98 Molecular diagnostics market: Product movement analysis
Fig. 99 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 100 Reagents market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 101 Others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 102 Molecular diagnostics market: Test location outlook and key takeaways
Fig. 103 Molecular diagnostics market: Test location movement analysis
Fig. 104 PoC market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 105 Self-test or over the counter market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 106 Central laboratories market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 107 Molecular diagnostics market: Technology outlook and key takeaways
Fig. 108 Molecular diagnostics market: Technology movement analysis
Fig. 109 Polymerase chain reaction (PCR) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 110 Nucleic acid extraction and purification market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 111 Others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 112 Multiplex PCR market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 113 Other PCR market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 114 Instruments PCR market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 115 Reagents PCR market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 116 Others PCR market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 117 In situ hybridization (ISH) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 118 Instruments ISH market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 119 Reagents ISH market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 120 Others ISH market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 121 INAAT market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 122 Instruments INAAT market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 123 Reagents INAAT market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 124 Others INAAT market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 125 Chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 126 Instruments chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 127 Reagents chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 128 Others chips and microarrays market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 129 Mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 130 Instruments mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 131 Reagents mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 132 Others mass spectrometry market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 133 Sequencing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 134 Instruments sequencing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 135 Reagents sequencing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 136 Others sequencing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 137 Transcription Mediated Amplification (TMA) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 138 Instruments TMA market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 139 Reagents TMA market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 140 Others TMA market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 141 Others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 142 Instruments others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 143 Reagents others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 144 Others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 145 Molecular diagnostics market: Application outlook and key takeaways
Fig. 146 Molecular diagnostics market: Application movement analysis
Fig. 147 Oncology market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 148 Breast cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 149 Prostate cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 150 Colorectal cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 151 Cervical cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 152 Kidney cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 153 Liver cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 154 Blood cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 155 Lung cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 156 Other cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 157 Pharmacogenomics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 158 Infectious diseases market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 159 MRSA market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 160 Clostridium difficile market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 161 VRE market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 162 Carbapenem-resistant bacteria market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 163 Flu market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 164 RSV market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 165 Candida market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 166 TB and drug-resistant TB market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 167 Meningitis cancer market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 168 Gastrointestinal panel testing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 169 Chlamydia market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 170 Gonorrhea market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 171 HIV market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 172 Hepatitis C market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 173 Hepatitis B market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 174 Other infectious disease market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 175 Genetic testing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 176 Newborn screening market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 177 Predictive and presymptomatic testing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 178 Other genetic testing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 179 Neurological diseases market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 180 Cardiovascular diseases market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 181 Microbiology market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 182 Others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 183 Molecular diagnostics market: Regional outlook and key takeaways
Fig. 184 Molecular diagnostics market: Regional movement analysis
Fig. 185 North America
Fig. 186 North America, SWOT
Fig. 187 North America market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 188 U.S.
Fig. 189 U.S. market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 190 Canada
Fig. 191 Canada market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 192 Europe
Fig. 193 Europe, SWOT
Fig. 194 Europe market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 195 U.K.
Fig. 196 U.K. market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 197 Germany
Fig. 198 Germany market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 199 France
Fig. 200 France market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 201 Spain
Fig. 202 Spain market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 203 Italy
Fig. 204 Italy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 205 Belgium
Fig. 206 Belgium market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 207 Switzerland
Fig. 208 Switzerland market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 209 Netherlands
Fig. 210 Netherlands market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 211 Poland
Fig. 212 Poland market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 213 Austria
Fig. 214 Austria market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 215 Greece
Fig. 216 Greece market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 217 Sweden
Fig. 218 Sweden market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 219 Turkey
Fig. 220 Turkey market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 221 Finland
Fig. 222 Finland market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 223 Asia Pacific
Fig. 224 Asia Pacific, SWOT
Fig. 225 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 226 Japan
Fig. 227 Japan market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 228 China
Fig. 229 China. market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 230 India
Fig. 231 India market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 232 Australia
Fig. 233 Australia market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 234 New Zealand
Fig. 235 New Zealand market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 236 Sri Lanka
Fig. 237 Sri Lanka market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 238 Malaysia
Fig. 239 Malaysia market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 240 Thailand
Fig. 241 Thailand market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 242 Vietnam
Fig. 243 Vietnam market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 244 Singapore
Fig. 245 Singapore market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 246 Latin America
Fig. 247 Latin America, SWOT
Fig. 248 Latin America. market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 249 Brazil
Fig. 250 Brazil market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 251 Mexico
Fig. 252 Mexico market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 253 Colombia
Fig. 254 Colombia market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 255 Chile
Fig. 256 Chile market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 257 Peru
Fig. 258 Peru market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 259 Argentina
Fig. 260 Argentina market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 261 Middle East & Africa
Fig. 262 Middle East & Africa, SWOT
Fig. 263 Middle East & Africa market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 264 South Africa
Fig. 265 South Africa market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 266 Saudi Arabia
Fig. 267 Saudi Arabia market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 268 Jordan
Fig. 269 Jordan market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 270 United Arab Emirates
Fig. 271 United Arab Emirates market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 272 Qatar
Fig. 273 Qatar market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 274 Nigeria
Fig. 275 Nigeria market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 276 Egypt
Fig. 277 Egypt market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 278 Strategy Framework
Fig. 279 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.